-
EP1345902
European procedure
Extract from the Register of European Patents
EP About this file: EP1345902
| EP1345902 - SUBSTITUTED HETEROCYCLO-NORBORNYLAMINE DERIVATIVES, METHOD FOR PRODUCING THE SAME, THEIR USE AS MEDICAMENT OR DIAGNOSTIC AGENT AND MEDICAMENT CONTAINING THE SAME [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.04.2006 Database last updated on 11.05.2024 | Most recent event Tooltip | 13.04.2007 | Lapse of the patent in a contracting state New state(s): CY | published on 16.05.2007 [2007/20] | Applicant(s) | For all designated states Aventis Pharma Deutschland GmbH Brüningstrasse 50 65929 Frankfurt am Main / DE | [2003/39] | Inventor(s) | 01 /
HEINELT, Uwe Mosbacher Strasse 54 65187 Wiesbaden / DE | 02 /
LANG, Hans-Jochen Rüdesheimer Strasse 7 65719 Hofheim / DE | 03 /
WIRTH, Klaus Robert-Schumann-Ring 104 65830 Kriftel / DE | 04 /
JANSEN, Hans-Willi Distelweg 25 65527 Niedernhausen / DE | [2003/39] | Application number, filing date | 01273771.4 | 07.12.2001 | [2003/39] | WO2001EP14422 | Priority number, date | DE2000163294 | 19.12.2000 Original published format: DE 10063294 | [2003/39] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO02066431 | Date: | 29.08.2002 | Language: | DE | [2002/35] | Type: | A1 Application with search report | No.: | EP1345902 | Date: | 24.09.2003 | Language: | DE | The application published by WIPO in one of the EPO official languages on 29.08.2002 takes the place of the publication of the European patent application. | [2003/39] | Type: | B1 Patent specification | No.: | EP1345902 | Date: | 01.06.2005 | Language: | DE | [2005/22] | Search report(s) | International search report - published on: | EP | 29.08.2002 | Classification | IPC: | C07D213/38, C07D307/52, C07D333/20, A61P9/00, A61P1/00, A61K31/381, A61K31/417, A61K31/40, C07D277/28, A61K31/426, C07D241/12, A61K31/4965, C07D239/26, A61K31/505, C07D237/08, A61K31/50, C07D231/12, C07D231/10, A61K31/415, C07D333/28, C07D333/44 | [2003/39] | CPC: |
C07D207/335 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/10 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P25/00 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P3/12 (EP);
A61P33/14 (EP);
A61P35/00 (EP);
A61P39/00 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P7/10 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D213/38 (EP,US);
C07D231/12 (EP,US);
C07D231/16 (EP,US);
C07D233/56 (EP,US);
C07D233/64 (EP,US);
C07D237/08 (EP,US);
C07D239/26 (EP,US);
C07D241/12 (EP,US);
C07D249/08 (EP,US);
C07D261/18 (EP,US);
C07D277/28 (EP,US);
C07D307/52 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/39] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | SUBSTITUIERTE HETEROCYCLO-NORBORNYLAMINO-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG, IHRE VERWENDUNG ALS MEDIKAMENT ODER DIAGNOSTIKUM SOWIE SIE ENTHALTENDES MEDIKAMENT | [2003/39] | English: | SUBSTITUTED HETEROCYCLO-NORBORNYLAMINE DERIVATIVES, METHOD FOR PRODUCING THE SAME, THEIR USE AS MEDICAMENT OR DIAGNOSTIC AGENT AND MEDICAMENT CONTAINING THE SAME | [2003/39] | French: | DERIVES HETEROCYCLO-NORBONYLAMINO SUBSTITUES, LEUR PROCEDE DE PRODUCTION, LEUR UTILISATION COMME MEDICAMENT OU AGENT DE DIAGNOSTIC ET MEDICAMENT LES CONTENANT | [2003/39] | Entry into regional phase | 21.07.2003 | National basic fee paid | 21.07.2003 | Designation fee(s) paid | 21.07.2003 | Examination fee paid | Examination procedure | 06.07.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 21.07.2003 | Examination requested [2003/39] | 16.11.2004 | Communication of intention to grant the patent | 29.03.2005 | Fee for grant paid | 29.03.2005 | Fee for publishing/printing paid | Opposition(s) | 02.03.2006 | No opposition filed within time limit [2006/21] | Fees paid | Renewal fee | 02.01.2004 | Renewal fee patent year 03 | 03.01.2005 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | TR | 01.06.2005 | CY | 07.12.2005 | LU | 31.12.2005 | MC | 31.12.2005 | [2007/20] |
| Former [2007/09] | TR | 01.06.2005 | |
| LU | 31.12.2005 | ||
| MC | 31.12.2005 | ||
| Former [2006/51] | TR | 01.06.2005 | |
| MC | 31.12.2005 | ||
| Former [2006/40] | MC | 31.12.2005 | Cited in | International search | [PAD]WO0144164 (AVENTIS PHARMA GMBH [DE]) [PAD] 1-21* the whole document * |